China's Aureka Biotechnologies Raises Tens of...

Aureka Biotechnologies, a biotechnology company developing AI-powered antibody therapies, said it has raised tens of millions of U.S. dollars in a Series A funding round co-led by 5Y Capital and Qiming Venture Partners. Existing backer NRL Capital and new investors including Agentic Ventures also participated.

The proceeds will be used to advance Aureka’s therapeutic pipeline toward key clinical m